Atlas Trials

Fred Hutchinson Cancer Center

541 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Fred Hutchinson Cancer Center

RecordFirmDate
Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01342887)Fred Hutchinson Cancer Center2011-04-01
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure (NCT01335932)Fred Hutchinson Cancer Center2011-03-10
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (NCT01206309)Fred Hutchinson Cancer Center2011-03-01
Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT01252667)Fred Hutchinson Cancer Center2011-01-25
Meals and Grazing Study (NCT02548026)Fred Hutchinson Cancer Center2011-01-01
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT01251575)Fred Hutchinson Cancer Center2010-12-01
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy (NCT01235572)Fred Hutchinson Cancer Center2010-12-01
Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells (NCT01097057)Fred Hutchinson Cancer Center2010-11-09
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant (NCT01231412)Fred Hutchinson Cancer Center2010-11-01
MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation (NCT01178892)Fred Hutchinson Cancer Center2010-11-01
Vitamin D, Diet and Activity Study (NCT01240213)Fred Hutchinson Cancer Center2010-10-01
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma (NCT00992446)Fred Hutchinson Cancer Center2010-09-02
Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS (NCT01141725)Fred Hutchinson Cancer Center2010-09-01
Effects of Sulforaphane on Normal Prostate Tissue (NCT00946309)Fred Hutchinson Cancer Center2010-07-01
WebQuit Online Smoking Cessation Study (NCT01166334)Fred Hutchinson Cancer Center2010-06-01
Malaria Clinical Trials Center General Screening (NCT02119312)Fred Hutchinson Cancer Center2010-06-01
Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01076270)Fred Hutchinson Cancer Center2010-06-01
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01028716)Fred Hutchinson Cancer Center2010-05-19
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients (NCT01141959)Fred Hutchinson Cancer Center2010-05-01
Screening Mammography and Latinas: A Multilevel Intervention (NCT02010008)Fred Hutchinson Cancer Center2010-05-01
Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome (NCT00988715)Fred Hutchinson Cancer Center2010-04-21
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma (NCT01106235)Fred Hutchinson Cancer Center2010-04-01
Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant (NCT01083706)Fred Hutchinson Cancer Center2010-04-01
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia (NCT01008462)Fred Hutchinson Cancer Center2010-03-18
Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD (NCT00914940)Fred Hutchinson Cancer Center2009-12-17
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer (NCT00968630)Fred Hutchinson Cancer Center2009-12-17
A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women (NCT01121640)Fred Hutchinson Cancer Center2009-11-01
Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders (NCT00919503)Fred Hutchinson Cancer Center2009-07-31
Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma (NCT00945269)Fred Hutchinson Cancer Center2009-07-01
Health SMART (Stress Management and Relaxation Training) (NCT01048528)Fred Hutchinson Cancer Center2009-07-01
MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women (NCT00894543)Fred Hutchinson Cancer Center2009-07-01
Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma (NCT01005537)Fred Hutchinson Cancer Center2009-06-01
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00918723)Fred Hutchinson Cancer Center2009-06-01
Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease (NCT00929695)Fred Hutchinson Cancer Center2009-06-01
TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients (NCT00867139)Fred Hutchinson Cancer Center2009-03-01
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas (NCT00669669)Fred Hutchinson Cancer Center2009-02-25
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant (NCT00796068)Fred Hutchinson Cancer Center2009-02-24
Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma (NCT00860171)Fred Hutchinson Cancer Center2009-02-01
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia (NCT00860574)Fred Hutchinson Cancer Center2009-02-01
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant (NCT00833534)Fred Hutchinson Cancer Center2009-02-01
Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant (NCT00839956)Fred Hutchinson Cancer Center2009-02-01
Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma (NCT00871481)Fred Hutchinson Cancer Center2009-02-01
Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma (NCT00867529)Fred Hutchinson Cancer Center2009-02-01
Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT00844441)Fred Hutchinson Cancer Center2008-12-01
Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS (NCT00839982)Fred Hutchinson Cancer Center2008-11-01
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer (NCT00789776)Fred Hutchinson Cancer Center2008-10-13
Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma (NCT00793572)Fred Hutchinson Cancer Center2008-10-01
Blood Samples to Evaluate Biomarkers of Donor Chimerism (NCT00764829)Fred Hutchinson Cancer Center2008-09-01
Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML (NCT00702403)Fred Hutchinson Cancer Center2008-08-14
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant (NCT00795769)Fred Hutchinson Cancer Center2008-08-08
Prevention of Ovarian Cancer in Women Participating in Mammography (NCT01851109)Fred Hutchinson Cancer Center2008-07-01
Partnership for a Hispanic Diabetes Prevention Program (NCT01564797)Fred Hutchinson Cancer Center2008-07-01
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00723099)Fred Hutchinson Cancer Center2008-06-25
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases (NCT00716066)Fred Hutchinson Cancer Center2008-06-01
Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT00673153)Fred Hutchinson Cancer Center2008-03-01
Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant (NCT00619684)Fred Hutchinson Cancer Center2008-02-01
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome (NCT00589316)Fred Hutchinson Cancer Center2007-10-05
Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection (NCT00547235)Fred Hutchinson Cancer Center2007-09-01
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00555048)Fred Hutchinson Cancer Center2007-09-01
Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma (NCT00553306)Fred Hutchinson Cancer Center2007-09-01
Improving Outcomes Assessment in Chronic GVHD (NCT00637689)Fred Hutchinson Cancer Center2007-09-01
Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma (NCT00621452)Fred Hutchinson Cancer Center2007-08-01
Yoga Study in Breast Cancer Patients (NCT00476203)Fred Hutchinson Cancer Center2007-05-01
Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement (NCT00548392)Fred Hutchinson Cancer Center2007-05-01
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00489203)Fred Hutchinson Cancer Center2007-04-01
Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission (NCT00476047)Fred Hutchinson Cancer Center2007-02-01
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia (NCT00453388)Fred Hutchinson Cancer Center2007-02-01
Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma (NCT00445692)Fred Hutchinson Cancer Center2007-01-10
Colombian Screening Mammography Project (NCT02337582)Fred Hutchinson Cancer Center2007-01-01
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases (NCT00450983)Fred Hutchinson Cancer Center2006-12-01
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome (NCT00445744)Fred Hutchinson Cancer Center2006-12-01
Effects of Garlic Supplements on Opioids in Healthy Volunteers (NCT00499460)Fred Hutchinson Cancer Center2006-11-01
Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis (NCT00622895)Fred Hutchinson Cancer Center2006-09-01
Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma (NCT00438841)Fred Hutchinson Cancer Center2006-08-01
Spouses/Partners Expressing Their Thoughts After Transplant (NCT01061801)Fred Hutchinson Cancer Center2006-08-01
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant (NCT00410657)Fred Hutchinson Cancer Center2006-07-01
Carbohydrates and Related Biomarkers (NCT00622661)Fred Hutchinson Cancer Center2006-06-01
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders (NCT00553098)Fred Hutchinson Cancer Center2006-06-01
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant (NCT00408681)Fred Hutchinson Cancer Center2006-06-01
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders (NCT00358657)Fred Hutchinson Cancer Center2006-05-24
Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant (NCT00357084)Fred Hutchinson Cancer Center2006-05-01
A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies (NCT00343798)Fred Hutchinson Cancer Center2006-04-01
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer (NCT00346359)Fred Hutchinson Cancer Center2006-03-01
Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant (NCT00354419)Fred Hutchinson Cancer Center2006-02-01
Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant (NCT00343785)Fred Hutchinson Cancer Center2006-02-01
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders (NCT00397813)Fred Hutchinson Cancer Center2006-01-01
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia (NCT00322101)Fred Hutchinson Cancer Center2006-01-01
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease (NCT00719888)Fred Hutchinson Cancer Center2005-11-18
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease (NCT00719849)Fred Hutchinson Cancer Center2005-11-01
Effect of Aspirin on Mammogram Density in Healthy Postmenopausal Women With a Moderate or High Level of Breast Density (NCT00470561)Fred Hutchinson Cancer Center2005-11-01
Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma (NCT00378768)Fred Hutchinson Cancer Center2005-11-01
Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma (NCT00313625)Fred Hutchinson Cancer Center2005-09-01
Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response (NCT00121160)Fred Hutchinson Cancer Center2005-09-01
Move and Moderate in Balance (NCT00715130)Fred Hutchinson Cancer Center2005-09-01
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma (NCT00217438)Fred Hutchinson Cancer Center2005-07-01
Effects of Garlic Supplements on Drug Metabolism (NCT00122889)Fred Hutchinson Cancer Center2005-07-01
Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases (NCT00317785)Fred Hutchinson Cancer Center2005-05-01
Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer (NCT00217568)Fred Hutchinson Cancer Center2005-05-01
Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant (NCT00920842)Fred Hutchinson Cancer Center2005-04-01
Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia (NCT00119340)Fred Hutchinson Cancer Center2005-04-01
← Previous Next →

Track Fred Hutchinson Cancer Center automatically

Every clearance here is in the API, with alerts when new ones post.